News Releases

Cancer Center Ranked High Performing by "US News & World Report"
August 27th, 2015

Dartmouth's Norris Cotton Cancer Center (NCCC) is the only cancer center in northern New England to be ranked as "high performing" by US News and World Report.

Novel Technique Makes Cytotoxic Molecules for Drug Development
August 25th, 2015

Dartmouth investigators developed a means to artificially synthesize a class of extremely cytotoxic compounds to combat cancer and disease.

Some Gene Chromosomes More Risk Associated with Disease
August 25th, 2015

A pair of genes located on a specific chromosome can be more frequently risk-associated with disease than protective.

Research Finds Telomere Length Predictive of Lung Adenocarcinoma
July 30th, 2015

The genetic risk score for long telomere length was associated with increased risk of lung adenocarcinoma, but not squamous cell lung cancer, prostate, breast, ovarian, or colorectal cancers.

Molecular Tumor Board Specifies Precision Medicine for Patients
July 28th, 2015

At Dartmouth’s Norris Cotton Cancer Center (NCCC), investigators have teamed up with oncologists to make genetic profiling of tumors clinically actionable.

Myeloid-Derived Suppressors Cells Fertile Ground for Research
July 21st, 2015

Known for their role in tumor cell systems, monocytic myeloid-derived suppressor cells hold significance in suppression of immune responses during infectious diseases.

Under Sunny Skies, Prouty Raises More Than $3.1 Million
July 11th, 2015

With the day feeling like a million dollars, more than 5,000 participants and some 1,300 volunteers teamed up to triple the feeling by raising more than $3.1 million for cancer care and research.

Combining MRI, NIRST Increases Specificity in Breast Imaging
July 9th, 2015

Investigators from Norris Cotton Cancer Center demonstrated that a dual breast exam using MRI and Near Infrared Spectral Tomography (NIRST) is feasible and more accurate than MRI alone.

Breast Cancer Gene Signature Predicts Bladder Cancer Progression
June 25th, 2015

Investigators harnessed genomic data to discover that the previously identified E2F4 signature in breast cancer can be utilized to predict prognosis and response to therapy in bladder cancer.

Researchers Determine How Melanoma Tumors Evade Immune System
June 18th, 2015

In a mouse model of melanoma, investigators from Norris Cotton Cancer Center found that chemo-attractive signals that direct immune cells into tumors are actively suppressed by the cancer.